skip to content
Drug safety : hearings before a subcommittee of the Committee on Government Operations, House of Representatives, Eighty-eighth Congress, second session. Preview this item
ClosePreview this item
Checking...

Drug safety : hearings before a subcommittee of the Committee on Government Operations, House of Representatives, Eighty-eighth Congress, second session.

Author: United States. Congress. House. Committee on Government Operations. Intergovernmental Relations Subcommittee.; United States. Congress. House. Committee on Government Operations.
Publisher: Washington : U.S. G.P.O., 1964-
Edition/Format:   Print book : National government publication : EnglishView all editions and formats
Summary:
Hearings held July 20, 22, 27, Aug. 3, 10, Sept. 24, 1965--pt. 4.

Hearings held Mar. 9, 10, May 25, 26, June 7-9, 1966--pt. 5.

Pt. 1--Surveys FDA, AMA, and pharmaceutical industry drug safety research and regulatory programs.

Pt. 2--Surveys VA and NIH drug safety research programs, and investigates FDA drug approval process for Flexin and Orabilex.

Pt. 3--Continuation of hearing on controls over drugs that may be released for public consumption. Examines FDA organization, policies and procedures for processing applications for testing investigational drugs. Focuses in part on the anti-depressant drug Parnate that was approved for sale but taken off the market.

Pt. 4--Continuation of hearing on controls over drugs that may be released for public consumption. Examines FDA role in monitoring pharmaceutical companies manufacturing practices. Focuses in part on case involving mixup of labels on a number of drugs produced by Abbott Laboratories of North Chicago, Ill.

Pt. 5--Continuation of hearings on FDA drug safety regulations and requirements. Focuses on approval of DMSO (dimethyl sulfoxide).  Read more...

Rating:

(not yet rated) 0 with reviews - Be the first.

Subjects
More like this

Find a copy in the library

&AllPage.SpinnerRetrieving; Finding libraries that hold this item...

Details

Additional Physical Format: Online version:
United States. Congress. House. Committee on Government Operations. Intergovernmental Relations Subcommittee.
Drug safety.
Washington : U.S. G.P.O., 1964-
(OCoLC)1084208998
Material Type: Government publication, National government publication
Document Type: Book
All Authors / Contributors: United States. Congress. House. Committee on Government Operations. Intergovernmental Relations Subcommittee.; United States. Congress. House. Committee on Government Operations.
OCLC Number: 14550166
Notes: "Intergovernmental Relations Subcommittee'--Pt. 1, page 1.
Hearings held before the Eighty-eighth Congress, second session and other sessions of later Congresses.
Description: 5 volumes : illustrations ; 23 cm

Abstract:

Hearings held July 20, 22, 27, Aug. 3, 10, Sept. 24, 1965--pt. 4.

Hearings held Mar. 9, 10, May 25, 26, June 7-9, 1966--pt. 5.

Pt. 1--Surveys FDA, AMA, and pharmaceutical industry drug safety research and regulatory programs.

Pt. 2--Surveys VA and NIH drug safety research programs, and investigates FDA drug approval process for Flexin and Orabilex.

Pt. 3--Continuation of hearing on controls over drugs that may be released for public consumption. Examines FDA organization, policies and procedures for processing applications for testing investigational drugs. Focuses in part on the anti-depressant drug Parnate that was approved for sale but taken off the market.

Pt. 4--Continuation of hearing on controls over drugs that may be released for public consumption. Examines FDA role in monitoring pharmaceutical companies manufacturing practices. Focuses in part on case involving mixup of labels on a number of drugs produced by Abbott Laboratories of North Chicago, Ill.

Pt. 5--Continuation of hearings on FDA drug safety regulations and requirements. Focuses on approval of DMSO (dimethyl sulfoxide).

Reviews

User-contributed reviews
Retrieving GoodReads reviews...
Retrieving DOGObooks reviews...

Tags

Be the first.
Confirm this request

You may have already requested this item. Please select Ok if you would like to proceed with this request anyway.

Linked Data


Primary Entity

<http://www.worldcat.org/oclc/14550166> # Drug safety : hearings before a subcommittee of the Committee on Government Operations, House of Representatives, Eighty-eighth Congress, second session.
    a schema:Book, schema:CreativeWork ;
    library:oclcnum "14550166" ;
    library:placeOfPublication <http://experiment.worldcat.org/entity/work/data/7986995#Place/washington> ; # Washington
    library:placeOfPublication <http://id.loc.gov/vocabulary/countries/dcu> ;
    schema:about <http://id.worldcat.org/fast/898830> ; # Drugs--Law and legislation
    schema:about <http://dewey.info/class/614.34/> ;
    schema:about <http://experiment.worldcat.org/entity/work/data/7986995#Topic/pharmaceutical_preparations> ; # Pharmaceutical Preparations
    schema:about <http://id.loc.gov/authorities/subjects/sh2008102437> ; # Drugs--Law and legislation--United States
    schema:about <http://id.worldcat.org/fast/1204155> ; # United States.
    schema:bookFormat bgn:PrintBook ;
    schema:contributor <http://viaf.org/viaf/139472198> ; # United States. Congress. House. Committee on Government Operations.
    schema:creator <http://viaf.org/viaf/157093194> ; # United States. Congress. House. Committee on Government Operations. Intergovernmental Relations Subcommittee.
    schema:datePublished "1964" ;
    schema:datePublished "1964/" ;
    schema:description "Pt. 3--Continuation of hearing on controls over drugs that may be released for public consumption. Examines FDA organization, policies and procedures for processing applications for testing investigational drugs. Focuses in part on the anti-depressant drug Parnate that was approved for sale but taken off the market."@en ;
    schema:description "Pt. 4--Continuation of hearing on controls over drugs that may be released for public consumption. Examines FDA role in monitoring pharmaceutical companies manufacturing practices. Focuses in part on case involving mixup of labels on a number of drugs produced by Abbott Laboratories of North Chicago, Ill."@en ;
    schema:description "Pt. 1--Surveys FDA, AMA, and pharmaceutical industry drug safety research and regulatory programs."@en ;
    schema:description "Pt. 2--Surveys VA and NIH drug safety research programs, and investigates FDA drug approval process for Flexin and Orabilex."@en ;
    schema:description "Hearings held July 20, 22, 27, Aug. 3, 10, Sept. 24, 1965--pt. 4."@en ;
    schema:description "Hearings held Mar. 9, 10, May 25, 26, June 7-9, 1966--pt. 5."@en ;
    schema:description "Pt. 5--Continuation of hearings on FDA drug safety regulations and requirements. Focuses on approval of DMSO (dimethyl sulfoxide)."@en ;
    schema:exampleOfWork <http://worldcat.org/entity/work/id/7986995> ;
    schema:genre "Government publication"@en ;
    schema:genre "National government publication"@en ;
    schema:inLanguage "en" ;
    schema:isSimilarTo <http://www.worldcat.org/oclc/1084208998> ;
    schema:name "Drug safety : hearings before a subcommittee of the Committee on Government Operations, House of Representatives, Eighty-eighth Congress, second session."@en ;
    schema:productID "14550166" ;
    schema:publication <http://www.worldcat.org/title/-/oclc/14550166#PublicationEvent/washington_u_s_g_p_o_1964> ;
    schema:publisher <http://experiment.worldcat.org/entity/work/data/7986995#Agent/u_s_g_p_o> ; # U.S. G.P.O.
    wdrs:describedby <http://www.worldcat.org/title/-/oclc/14550166> ;
    .


Related Entities

<http://experiment.worldcat.org/entity/work/data/7986995#Agent/u_s_g_p_o> # U.S. G.P.O.
    a bgn:Agent ;
    schema:name "U.S. G.P.O." ;
    .

<http://experiment.worldcat.org/entity/work/data/7986995#Topic/pharmaceutical_preparations> # Pharmaceutical Preparations
    a schema:Intangible ;
    schema:name "Pharmaceutical Preparations"@en ;
    .

<http://id.loc.gov/authorities/subjects/sh2008102437> # Drugs--Law and legislation--United States
    a schema:Intangible ;
    schema:name "Drugs--Law and legislation--United States"@en ;
    .

<http://id.worldcat.org/fast/1204155> # United States.
    a schema:Place ;
    schema:name "United States." ;
    .

<http://id.worldcat.org/fast/898830> # Drugs--Law and legislation
    a schema:Intangible ;
    schema:name "Drugs--Law and legislation"@en ;
    .

<http://viaf.org/viaf/139472198> # United States. Congress. House. Committee on Government Operations.
    a schema:Organization ;
    schema:name "United States. Congress. House. Committee on Government Operations." ;
    .

<http://viaf.org/viaf/157093194> # United States. Congress. House. Committee on Government Operations. Intergovernmental Relations Subcommittee.
    a schema:Organization ;
    schema:name "United States. Congress. House. Committee on Government Operations. Intergovernmental Relations Subcommittee." ;
    .

<http://www.worldcat.org/oclc/1084208998>
    a schema:CreativeWork ;
    rdfs:label "Drug safety." ;
    schema:description "Online version:" ;
    schema:isSimilarTo <http://www.worldcat.org/oclc/14550166> ; # Drug safety : hearings before a subcommittee of the Committee on Government Operations, House of Representatives, Eighty-eighth Congress, second session.
    .

<http://www.worldcat.org/title/-/oclc/14550166>
    a genont:InformationResource, genont:ContentTypeGenericResource ;
    schema:about <http://www.worldcat.org/oclc/14550166> ; # Drug safety : hearings before a subcommittee of the Committee on Government Operations, House of Representatives, Eighty-eighth Congress, second session.
    schema:dateModified "2019-02-03" ;
    void:inDataset <http://purl.oclc.org/dataset/WorldCat> ;
    .


Content-negotiable representations

Close Window

Please sign in to WorldCat 

Don't have an account? You can easily create a free account.